These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23035176)

  • 1. Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.
    Fujii J; Naito M; Yutsudo T; Matsumoto S; Heatherly DP; Yamada T; Kobayashi H; Yoshida S; Obrig T
    Clin Vaccine Immunol; 2012 Dec; 19(12):1932-7. PubMed ID: 23035176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.
    Lu X; Skurnik D; Pozzi C; Roux D; Cywes-Bentley C; Ritchie JM; Munera D; Gening ML; Tsvetkov YE; Nifantiev NE; Waldor MK; Pier GB
    mBio; 2014 Mar; 5(2):e00974-14. PubMed ID: 24667709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
    McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with BLS-Stx2B chimera totally protects dams from early pregnancy loss induced by Shiga toxin type 2 (Stx2) and confers anti-Stx2 immunity to the offspring.
    Sacerdoti F; Mejías MP; Bruballa AC; Alvarez RS; Amaral MM; Palermo MS; Ibarra C
    Vaccine; 2016 Sep; 34(39):4732-4737. PubMed ID: 27527816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli.
    Won G; Kim TH; Lee JH
    BMC Vet Res; 2017 Feb; 13(1):40. PubMed ID: 28143511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7082-7. PubMed ID: 16641102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric protein-based vaccine elicits a strong IgG antibody response and confers partial protection against Shiga toxin-producing
    Montero DA; Garcia-Betancourt R; Vidal RM; Velasco J; Palacios PA; Schneider D; Vega C; Gómez L; Montecinos H; Soto-Shara R; Oñate Á; Carreño LJ
    Front Immunol; 2023; 14():1186368. PubMed ID: 37575242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
    Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
    Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
    Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
    Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifaceted immune responses and protective efficacy elicited by a recombinant autolyzed Salmonella expressing FliC flagellar antigen of F18
    Won G; Lee JH
    Vaccine; 2016 Dec; 34(50):6335-6342. PubMed ID: 27817960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease.
    Sato T; Matsui T; Takita E; Kadoyama Y; Makino S; Kato K; Sawada K; Hamabata T
    J Vet Med Sci; 2013 Oct; 75(10):1309-15. PubMed ID: 23728257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent immune responses induced by a Salmonella ghost delivery system that expresses the recombinant Stx2eB, FedF, and FedA proteins of the Escherichia coli-producing F18 and Shiga toxin in a murine model and evaluation of its protective effect as a porcine vaccine candidate.
    Won G; John Hwa L
    Vet Q; 2017 Dec; 37(1):81-90. PubMed ID: 28317440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2.
    Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J
    Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant HcpA-EspA-Tir-Stx2B chimeric protein induces immunity against attachment and toxicity of Escherichia coli O157:H7.
    Kordbacheh E; Nazarian S; Hajizadeh A; Fasihi-Ramandi M; Fathi J
    Microb Pathog; 2019 Apr; 129():176-182. PubMed ID: 30731187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves.
    Fingermann M; Avila L; De Marco MB; Vázquez L; Di Biase DN; Müller AV; Lescano M; Dokmetjian JC; Fernández Castillo S; Pérez Quiñoy JL
    Hum Vaccin Immunother; 2018; 14(9):2208-2213. PubMed ID: 29923791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae.
    Sreerohini S; Balakrishna K; Parida M
    APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.